Houston、TXにおける心血管疾患の臨床試験
Houstonとその周辺地域（約30マイル以内）の拠点で、心血管疾患に関する24件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
被験者募集中第2相
- Cardiovascular Specialists of Willowbrook, Houston
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
被験者募集中第3相
- Victorium Clinical Research, Houston
- Houston Research Institute, Houston
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
被験者募集中第4相
- Vital Heart and Vein, Humble · 17マイル先
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
被験者募集中第3相
- Clinical Trial Site, Houston
- Clinical Trial Site, Houston
- Clinical Trial Site, Houston
- 他7件
Zenith® Fenestrated+ Clinical Study
被験者募集中
- Memorial Hermann Texas Medical Center/UT Health, Houston
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
被験者募集中
- CHI Saint Luke's Health-Baylor Saint Luke's Medical Center, Houston
- Houston Methodist Hospital, Houston
- The University of Texas Health Science Center at Houston, Houston
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
被験者募集中
- Houston Methodist Hospital, Houston
- Memorial Hermann-Texas Medical Center, Houston
- Texas Heart Institute at Baylor St. Luke's Medical Center, Houston
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
被験者募集中第3相
- Baylor College Of Medicine, Houston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
被験者募集中第2相
- Clinical Research Site, Houston
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
被験者募集中第4相健康なボランティア歓迎
- University of Texas at Houston, Houston
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
被験者募集中観察研究
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
被験者募集中第3相
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
- 他4件
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
被験者募集中第3相
- East Texas Cardiology PA, Houston
- Baylor College of Medicine, Houston
- Cardiovascular Specialists of Willowbrook, Houston
- 他1件
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
被験者募集中第3相
- Kelsey Seybold Research Foundation, Houston
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
被験者募集中
- Baylor/Texas Heart, Houston
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
被験者募集中
- CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
- Houston Methodist, Houston
- UTHealth Memorial Hermann, Houston
Pivotal Study for the Cardiac Performance System (CPS)
被験者募集中観察研究
- Baylor College of Medicine, Houston
DeBakey Cardiovascular Magnetic Resonance Study
被験者募集中観察研究健康なボランティア歓迎
- Houston Methodist Hospital, Houston
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
被験者募集中第3相
- Vital Heart and Vein, Humble · 17マイル先
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
被験者募集中
- Houston Healthcare Medical Center, Houston
Randomized Trial of SGLT2i in Heart Transplant Recipients
被験者募集中第4相
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
被験者募集中第2相
- UT Health Houston, Houston
PARTNER 3 Trial - Aortic Valve-in-Valve
被験者募集中
- The University of Texas Health Science Center at Houston, Houston
他の都市における心血管疾患の試験
- Boston, MA37件の研究
- New York City, NY33件の研究
- Washington, DC29件の研究
- Dallas, TX23件の研究
- Atlanta, GA22件の研究
- Cleveland, OH22件の研究
- Chicago, IL21件の研究
- Philadelphia, PA21件の研究
- Pittsburgh, PA20件の研究
- St. Louis, MO20件の研究
- San Francisco, CA18件の研究
- Nashville, TN18件の研究
Houstonにおける他の研究
- 非小細胞肺癌145件の研究
- 乳がん126件の研究
- がん（全種類）121件の研究
- 転移性癌104件の研究
- 大腸癌102件の研究
- 卵巣がん89件の研究
- 急性骨髄性白血病85件の研究
- 肺がん78件の研究
- 前立腺がん76件の研究
- 子宮内膜がん68件の研究
- 膵臓がん61件の研究
- 悪性黒色腫59件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。